George Dailey

6.1k total citations · 2 hit papers
72 papers, 4.2k citations indexed

About

George Dailey is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, George Dailey has authored 72 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Endocrinology, Diabetes and Metabolism, 25 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in George Dailey's work include Diabetes Management and Research (47 papers), Diabetes Treatment and Management (44 papers) and Metabolism, Diabetes, and Cancer (24 papers). George Dailey is often cited by papers focused on Diabetes Management and Research (47 papers), Diabetes Treatment and Management (44 papers) and Metabolism, Diabetes, and Cancer (24 papers). George Dailey collaborates with scholars based in United States, Canada and Germany. George Dailey's co-authors include John E. Gerich, N. Nurjhan, G. Perriello, Michael Stümvoll, Julio Rosenstock, Richard M. Bergenstal, John B. Buse, John Welsh, Michael A. Wood and Andrew Ahmann and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and American Journal of Clinical Nutrition.

In The Last Decade

George Dailey

70 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus

1995 889 citations Michael Stümvoll, N. Nurjhan et al. New England Journal of Medicine profile →
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes

2010 651 citations Richard M. Bergenstal, John B. Buse et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George Dailey United States	30	2.9k	1.3k	1.2k	833	674	72	4.2k
Bruno Guerci France	39	3.6k 1.3×	1.6k 1.3×	1.3k 1.1×	1.1k 1.3×	515 0.8×	210	5.1k
Nebojša Lalić Serbia	29	2.3k 0.8×	980 0.8×	994 0.8×	460 0.6×	690 1.0×	137	4.0k
R. P. Robertson United States	26	1.6k 0.6×	2.1k 1.7×	808 0.7×	822 1.0×	668 1.0×	50	3.4k
Rudolf Prager Austria	38	2.5k 0.9×	1.4k 1.1×	1.2k 1.0×	543 0.7×	1.2k 1.8×	140	5.4k
Steven C. Griffen United States	28	1.8k 0.6×	1.1k 0.9×	888 0.7×	427 0.5×	707 1.0×	42	3.0k
Jack L. Leahy United States	35	2.3k 0.8×	2.1k 1.7×	1.3k 1.1×	1.1k 1.4×	665 1.0×	95	4.1k
Yoshifumi Saisho Japan	29	2.1k 0.7×	2.2k 1.7×	1.0k 0.8×	1.2k 1.5×	497 0.7×	111	3.9k
Francesco Purrello Italy	38	2.5k 0.9×	2.2k 1.7×	1.6k 1.3×	758 0.9×	817 1.2×	186	5.4k
Brunella Capaldo Italy	36	1.8k 0.6×	1.1k 0.9×	838 0.7×	277 0.3×	1.4k 2.1×	110	4.4k
A H Barnett United Kingdom	32	2.0k 0.7×	877 0.7×	776 0.6×	1.1k 1.3×	576 0.9×	110	4.2k

Countries citing papers authored by George Dailey

Since Specialization

Citations

This map shows the geographic impact of George Dailey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Dailey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Dailey more than expected).

Fields of papers citing papers by George Dailey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Dailey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Dailey. The network helps show where George Dailey may publish in the future.

Co-authorship network of co-authors of George Dailey

This figure shows the co-authorship network connecting the top 25 collaborators of George Dailey. A scholar is included among the top collaborators of George Dailey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Dailey. George Dailey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dailey, George, et al.. (2019). Efficacy and safety of lixisenatide as add‐on therapy to basal insulin in older adults with type 2 diabetes in the GetGoal‐O Study. Journal of Diabetes. 11(12). 971–981. 3 indexed citations

Dailey, George, John R. White, Jason Chao, et al.. (2018). Improved glycaemic control and lower hypoglycaemia risk with reduced prior oral antidiabetes drug therapy in patients with type 2 diabetes treated with insulin glargine 300 U/mL. Endocrinology Diabetes & Metabolism. 1(4). e00035–e00035. 2 indexed citations

Dailey, George. (2015). Empagliflozin: A new treatment option for patients with type 2diabetes mellitus. Drugs of today. 51(9). 519–519. 8 indexed citations

Kushner, Pamela, et al.. (2015). Recognizing and minimizing hypoglycemia: The need for individualized care. Postgraduate Medicine. 127(8). 801–807. 6 indexed citations

Shaefer, Charles F., et al.. (2014). Weight Change in Patients with Type 2 Diabetes Starting Basal Insulin Therapy: Correlates and Impact on Outcomes. Postgraduate Medicine. 126(6). 93–104. 14 indexed citations

Garg, Satish K., et al.. (2013). Diabetes Duration and the Efficacy and Safety of Insulin Glargine Versus Comparator Treatment in Patients with Type 2 Diabetes Mellitus. Endocrine Practice. 20(2). 120–128. 4 indexed citations

Buse, John B., George Dailey, Richard M. Bergenstal, et al.. (2011). Baseline Predictors of A1C Reduction in Adults Using Sensor-Augmented Pump Therapy or Multiple Daily Injection Therapy: The STAR 3 Experience. Diabetes Technology & Therapeutics. 13(6). 601–606. 12 indexed citations

Dailey, George. (2011). Early and Intensive Therapy for Management of Hyperglycemia and Cardiovascular Risk Factors in Patients With Type 2 Diabetes. Clinical Therapeutics. 33(6). 665–678. 51 indexed citations

Dailey, George, et al.. (2010). Relationship of Insulin Dose, A1c Lowering, and Weight in Type 2 Diabetes: Comparing Insulin Glargine and Insulin Detemir. Diabetes Technology & Therapeutics. 12(12). 1019–1027. 41 indexed citations

10.

Dailey, George, Poul Strange, & Matthew C. Riddle. (2009). Reconsideration of Severe Hypoglycemic Events in the Treat-to-Target Trial. Diabetes Technology & Therapeutics. 11(8). 477–479. 5 indexed citations

11.

Dailey, George. (2008). Beyond insulin replacement: addressing the additional needs of the diabetes patient. Diabetes Obesity and Metabolism. 10(s2). 83–97. 7 indexed citations

12.

Dailey, George. (2008). Optimum management of type 2 diabetes – timely introduction, optimization and intensification of basal insulin. Diabetes Obesity and Metabolism. 10(s2). 5–13. 7 indexed citations

13.

Dailey, George. (2005). Insulin secretagogues: Who, what, when, and how?. Current Diabetes Reports. 5(5). 329–332. 1 indexed citations

14.

Feinglos, Mark N., George Dailey, William T. Cefalu, et al.. (2004). Effect on glycemic control of the addition of 2.5mg glipizide GITS to metformin in patients with T2DM. Diabetes Research and Clinical Practice. 68(2). 167–175. 40 indexed citations

15.

Dailey, George. (2004). Fine-tuning therapy with basal insulin for optimal glycemic control in type 2 diabetes: a review. Current Medical Research and Opinion. 20(12). 2007–2014. 7 indexed citations

16.

Dailey, George, Mustafa A. Noor, Jong-Soon Park, Simon Bruce, & Fred T. Fiedorek. (2004). Glycemic control with Glyburide/Metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial. The American Journal of Medicine. 116(4). 223–229. 77 indexed citations

17.

Dailey, George, et al.. (2001). Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus. Clinical Therapeutics. 23(8). 1311–1320. 126 indexed citations

18.

Dailey, George, Guenther Boden, David G. Johnson, et al.. (2000). Effects of pulsatile intravenous insulin therapy on the progression of diabetic nephropathy. Metabolism. 49(11). 1491–1495. 22 indexed citations

19.

Nurjhan, N., G. Perriello, Michael Stümvoll, et al.. (1995). Glutamine: a major gluconeogenic precursor and vehicle for interorgan carbon transport in man.. Journal of Clinical Investigation. 95(1). 272–277. 141 indexed citations

20.

Stümvoll, Michael, N. Nurjhan, G. Perriello, George Dailey, & John E. Gerich. (1995). Metabolic Effects of Metformin in Non-Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine. 333(9). 550–554. 889 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact